Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide for beta-cell function in C-peptide positive type 1 diabetes
2014-005174-11Phase 2Terminated
- Sponsor
- Akademiska sjukhuset
- Start
- Aug 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetes mellitus type 1 (T1D) comparing Victoza with Placebo (2 arms). Primary endpoint: Change in stimulated C-peptide AUC from run-in to 1 year. Started Aug 2015; status: terminated.
02
Drugs
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2014-005174-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005174-11.